ARTICLE | Clinical News
CZ BioMed preclinical data
October 10, 2011 7:00 AM UTC
In mice, panrvlysin was well tolerated and induced tumor growth regression. Details were not disclosed. CZ BioMed said panrvlysin is an undisclosed genetically engineered oncolytic common cold-like vi...